| Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome H Sharif, L Wang, WL Wang, VG Magupalli, L Andreeva, Q Qiao, ... Nature 570 (7761), 338-343, 2019 | 596 | 2019 |
| The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate Y Li, P Trojer, CF Xu, P Cheung, A Kuo, WJ Drury, Q Qiao, TA Neubert, ... Journal of Biological Chemistry 284 (49), 34283-34295, 2009 | 331 | 2009 |
| An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance M He, HH Chiang, H Luo, Z Zheng, Q Qiao, L Wang, M Tan, R Ohkubo, ... Cell metabolism 31 (3), 580-591. e5, 2020 | 277 | 2020 |
| The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation Q Qiao, Y Li, Z Chen, M Wang, D Reinberg, RM Xu Journal of Biological Chemistry 286 (10), 8361-8368, 2011 | 194 | 2011 |
| Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly Q Qiao, C Yang, C Zheng, L Fontán, L David, X Yu, C Bracken, M Rosen, ... Molecular cell 51 (6), 766-779, 2013 | 189 | 2013 |
| AID recognizes structured DNA for class switch recombination Q Qiao, L Wang, FL Meng, JK Hwang, FW Alt, H Wu Molecular cell 67 (3), 361-373. e4, 2017 | 188 | 2017 |
| Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of … KG Weinacht, LM Charbonnier, F Alroqi, A Plant, Q Qiao, H Wu, C Ma, ... Journal of Allergy and Clinical Immunology 139 (5), 1629-1640. e2, 2017 | 171 | 2017 |
| A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton E Janssen, M Tohme, M Hedayat, M Leick, S Kumari, N Ramesh, ... The Journal of clinical investigation 126 (10), 3837-3851, 2016 | 113 | 2016 |
| Crystal structure of human IRAK1 L Wang, Q Qiao, R Ferrao, C Shen, JM Hatcher, SJ Buhrlage, NS Gray, ... Proceedings of the National Academy of Sciences 114 (51), 13507-13512, 2017 | 72 | 2017 |
| Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth L Fontán, Q Qiao, JM Hatcher, G Casalena, I Us, M Teater, M Durant, ... The Journal of clinical investigation 128 (10), 4397-4412, 2018 | 59 | 2018 |
| Mind bomb regulates cell death during TNF signaling by suppressing RIPK1’s cytotoxic potential R Feltham, K Jamal, T Tenev, G Liccardi, I Jaco, CM Domingues, O Morris, ... Cell reports 23 (2), 470-484, 2018 | 52 | 2018 |
| Structural basis for substrate preference of SMYD3, a SET domain-containing protein lysine methyltransferase W Fu, N Liu, Q Qiao, M Wang, J Min, B Zhu, RM Xu, N Yang Journal of Biological Chemistry 291 (17), 9173-9180, 2016 | 37 | 2016 |
| CIDE domains form functionally important higher-order assemblies for DNA fragmentation JY Choi, Q Qiao, SH Hong, CM Kim, JH Jeong, YG Kim, YK Jung, H Wu, ... Proceedings of the National Academy of Sciences 114 (28), 7361-7366, 2017 | 31 | 2017 |
| The CBM signalosome: potential therapeutic target for aggressive lymphoma? C Yang, L David, Q Qiao, E Damko, H Wu Cytokine & growth factor reviews 25 (2), 175-183, 2014 | 21 | 2014 |
| Peptide-based covalent inhibitors of MALT1 paracaspase JM Hatcher, G Du, L Fontán, I Us, Q Qiao, S Chennamadhavuni, J Shao, ... Bioorganic & Medicinal Chemistry Letters 29 (11), 1336-1339, 2019 | 17 | 2019 |
| Quinoline and thiazolopyridine allosteric inhibitors of MALT1 DA Scott, JM Hatcher, H Liu, M Fu, G Du, L Fontán, I Us, G Casalena, ... Bioorganic & Medicinal Chemistry Letters 29 (14), 1694-1698, 2019 | 16 | 2019 |
| Supramolecular organizing centers (SMOCs) as signaling machines in innate immune activation Q Qiao, H Wu Science China Life Sciences 58, 1067-1072, 2015 | 15 | 2015 |
| Understanding CARD tricks in apoptosomes L Wang, Q Qiao, H Wu Structure 25 (4), 575-577, 2017 | 10 | 2017 |
| Chemically induced degradation of MALT1 to treat B-cell lymphomas L Fontan, J Hatcher, D Scott, Q Qiao, I Us, G Du, M Durant, J Wilson, H Wu, ... Blood 134, 2073, 2019 | 7 | 2019 |
| MALT1 DEGRADATION FOR THE TREATMENT OF ACTIVATED B‐CELL TYPE DIFFUSE LARGE B‐CELL LYMPHOMA MR Seshadri, L Fontán, D Scott, J Hatcher, P Sreevatsan, G Du, Q Qiao, ... Hematological Oncology 39, 2021 | 1 | 2021 |
